Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.

Aiach M, Roncato M, Chadeuf G, Dezellus P, Capron L, Fiessinger JN.

Thromb Haemost. 1988 Aug 30;60(1):94-6.

PMID:
3187951
[PubMed - indexed for MEDLINE]
2.

Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").

Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.

J Clin Invest. 1986 Mar;77(3):887-93.

PMID:
3512602
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.

Austin RC, Rachubinski RA, Ofosu FA, Blajchman MA.

Blood. 1991 May 15;77(10):2185-9.

PMID:
2029579
[PubMed - indexed for MEDLINE]
Free Article
4.

Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.

Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.

Thromb Haemost. 1989 Feb 28;61(1):20-4.

PMID:
2749590
[PubMed - indexed for MEDLINE]
5.

A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.

Aiach M, Nora M, Fiessinger JN, Roncato M, François D, Gelas MA.

Thromb Res. 1985 Sep 1;39(5):559-70.

PMID:
4082101
[PubMed - indexed for MEDLINE]
6.

Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.

Tripodi A, Krachmalnicoff A, Mannucci PM.

Thromb Haemost. 1986 Dec 15;56(3):349-52.

PMID:
3563966
[PubMed - indexed for MEDLINE]
7.

Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.

Okajima K, Abe H, Maeda S, Motomura M, Tsujihata M, Nagataki S, Okabe H, Takatsuki K.

Blood. 1993 Mar 1;81(5):1300-5.

PMID:
8443391
[PubMed - indexed for MEDLINE]
Free Article
8.

Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation.

de Roux N, Chadeuf G, Molho-Sabatier P, Plouin PF, Aiach M.

Br J Haematol. 1990 Jun;75(2):222-7.

PMID:
2372510
[PubMed - indexed for MEDLINE]
9.

Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.

de Moerloose PA, Reber G, Vernet P, Minazio P, Bouvier CA.

Thromb Haemost. 1987 Apr 7;57(2):154-7.

PMID:
3603409
[PubMed - indexed for MEDLINE]
10.

Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.

Jørgensen M, Petersen LC, Thorsen S.

J Lab Clin Med. 1984 Aug;104(2):245-56.

PMID:
6747440
[PubMed - indexed for MEDLINE]
11.

Homozygous variant of antithrombin III: AT III Fontainebleau.

Boyer C, Wolf M, Vedrenne J, Meyer D, Larrieu MJ.

Thromb Haemost. 1986 Aug 20;56(1):18-22.

PMID:
3775688
[PubMed - indexed for MEDLINE]
12.

An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.

Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN.

Br J Haematol. 1987 Aug;66(4):515-22.

PMID:
3663508
[PubMed - indexed for MEDLINE]
13.

Antithrombin III Alger: a new homozygous AT III variant.

Fischer AM, Cornu P, Sternberg C, Mériane F, Dautzenberg MD, Chafa O, Beguin S, Desnos M.

Thromb Haemost. 1986 Apr 30;55(2):218-21.

PMID:
3715788
[PubMed - indexed for MEDLINE]
14.

Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.

Okajima K, Abe H, Wagatsuma M, Okabe H, Takatsuki K.

Am J Hematol. 1995 Jan;48(1):12-8.

PMID:
7832187
[PubMed - indexed for MEDLINE]
15.

Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity.

Devraj-Kizuk R, Chui DH, Prochownik EV, Carter CJ, Ofosu FA, Blajchman MA.

Blood. 1988 Nov;72(5):1518-23.

PMID:
3179438
[PubMed - indexed for MEDLINE]
Free Article
16.

Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.

Wolf M, Boyer C, Tripodi A, Meyer D, Larrieu MJ, Mannucci PM.

Blood. 1985 Feb;65(2):496-500.

PMID:
3967090
[PubMed - indexed for MEDLINE]
Free Article
17.

Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity.

Blajchman MA, Fernandez-Rachubinski F, Sheffield WP, Austin RC, Schulman S.

Blood. 1992 Mar 15;79(6):1428-34.

PMID:
1547341
[PubMed - indexed for MEDLINE]
Free Article
18.

Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.

Ireland H, Lane DA, Thompson E, Walker ID, Blench I, Morris HR, Freyssinet JM, Grunebaum L, Olds R, Thein SL.

Br J Haematol. 1991 Sep;79(1):70-4.

PMID:
1911389
[PubMed - indexed for MEDLINE]
19.

Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.

Wolf M, Boyer-Neumann C, Meyer D, Tripodi A, Mannucci PM, Larrieu MJ.

Thromb Haemost. 1987 Oct 28;58(3):888-92.

PMID:
3433251
[PubMed - indexed for MEDLINE]
20.

A new familial variant of antithrombin III: 'antithrombin III Paris'.

Wolf M, Boyer C, Lavergne JM, Larrieu MJ.

Br J Haematol. 1982 Jun;51(2):285-95.

PMID:
7082587
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk